An Evidence-Based Argument Is Often the Fastest Route to Immunotherapy Authorization
Many oncology practices are learning lessons about the importance of persistence, persuasion, and creativity in getting I/O drugs to the patients who need them.
Value Pioneer Looks to Scale Up His Innovations in Care
To implement its value-based models of care on a broader scale, Consultants in Medical Oncology and Hematology of Philadelphia has decided to join a large network of practices.
Dr Deek on the Investigation of Immune Cell Infiltration in MIBC
Hypofractionated and Conventionally Fractionated Radiotherapy Generate Similar QOL, Safety in Breast Cancer
Dr Hoppe on the Rationale for the CheckMate 744 Trial in Hodgkin Lymphoma
Dr Chuong on the Patterns of Guided Radiation Therapy in Pancreatic Cancer
2 Clarke Drive Cranbury, NJ 08512